Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
ZVRA similar filings
- 23 May 17 KemPharm, Inc. Reports First Quarter 2017 Results
- 10 May 17 KemPharm, Inc. Reports First Quarter 2017 Results
- 28 Mar 17 Changes in Registrant's Certifying Accountant
- 9 Mar 17 KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
- 15 Feb 17 Departure of Directors or Certain Officers
- 9 Jan 17 Regulation FD Disclosure
- 14 Dec 16 KemPharm’s KP415, An Investigational Prodrug of D-Methylphenidate, Completes Phase 1 Proof-of-Concept Trial for the Treatment of ADHD
Filing view
External links
Exhibit 99.2